Paul Industries provides validation and commissioning in New Hampshire for biologics and cell therapy plants, regenerative manufacturing facilities, medical device makers, research buildings and the clean utilities behind them, from the Seacoast and Manchester’s Millyard to Nashua and the Upper Valley. The work runs from commissioning plans and factory and site acceptance tests through installation, operational and performance qualification, computerized system validation and cleanroom certification, with protocols the site’s quality unit approves and reports it can defend in an FDA inspection. Paul Industries, headquartered at 256 Shore Drive, Kilmarnock, Virginia, delivers that work on its own installations or on systems already in place, as a design-build package or as a complete program.
Request a quote or call 201-450-8280
Validation and commissioning in New Hampshire, system by system
Validation and commissioning in New Hampshire covers the equipment, utilities, rooms and software that touch a regulated product, each with its own tests and acceptance criteria. Commissioning proves a system was installed as designed and works as intended; qualification proves, with documented evidence approved by the quality unit, that it is fit for its GMP use; and process validation proves that the manufacturing process, run on those qualified systems, consistently makes product of the required quality. The general method sits on the national validation and commissioning page. The table below shows what each system typically needs at a New Hampshire site.
| System | Commissioning checks | Qualification evidence | Where it appears in New Hampshire |
|---|---|---|---|
| Water for injection and purified water | Flow, velocity, temperature, sanitization cycle, alarms | Phased sampling against USP conductivity, TOC, microbial and endotoxin limits | Biologics plants in Portsmouth and West Lebanon |
| Clean steam and autoclaves | Steam quality tests, trap and drain function, cycle controls | Non-condensable gas, superheat and dryness results; load mapping and biological indicators | Biologics, cell therapy and research buildings |
| Bioreactors, CIP and SIP | Instrument loop checks, valve sequencing, interlocks | Cleaning coverage, temperature distribution in SIP, recipe and alarm testing | Seacoast and Upper Valley production suites |
| Cleanrooms and air handling | Airflow balance, pressure cascade, filter integrity | ISO 14644 classification, recovery, airflow visualization, monitoring setup | Cell therapy, regenerative and device cleanrooms |
| Controlled temperature units | Setpoint, alarms, door-open response | Empty and loaded temperature mapping, power failure recovery | Every regulated site |
| Automation and data systems | Point-to-point checks, network and historian connection | Part 11 controls: audit trail, access, electronic signatures, backup and restore | Every regulated site |
| Device process equipment | Utility connections, safety functions | Process validation under ISO 13485 clause 7.5.6, as the QMSR requires | Device plants in Nashua, Salem, Manchester and Keene |
Where New Hampshire’s regulated manufacturing sits
New Hampshire’s regulated manufacturing sits in four clusters: biologics and cell therapy on the Seacoast, regenerative manufacturing and biofabrication in Manchester, commercial biologics in the Upper Valley, and medical device and precision manufacturing across the southern tier. The plants named below are market facts that show what kind of qualification work the state generates.
Biologics and cell therapy around Portsmouth
Among biotech companies in Portsmouth, NH, Lonza anchors the Pease Tradeport. Its site there is one of the company’s mammalian manufacturing plants serving programs from clinical supply to commercial launch, and a joint Lonza and Vertex investment adds a Portsmouth plant of roughly 12,000 square meters dedicated to Vertex’s cell therapies for type 1 diabetes, which are derived from donor cells. Multi-product contract manufacturing of that kind brings constant qualification work: new suites, product changeovers that require cleaning validation, equipment added between campaigns, and periodic review of every qualified system. Cell therapy adds closed processing equipment, cryogenic storage and controlled rate freezers, each with its own qualification approach.
Biotech companies in Manchester, NH and the ReGen Valley
Biotech companies in Manchester, NH cluster around the Advanced Regenerative Manufacturing Institute in the Millyard, which runs BioFabUSA, a Department of Defense manufacturing innovation institute that began with an $80 million federal award in 2016, matched by more than $214 million from its members. In 2023 the Economic Development Administration named the region, branded ReGen Valley, one of its first 31 Tech Hubs, and in July 2024 awarded about $44 million to carry out projects in biofabrication, workforce training and manufacturing space.
Cell, tissue and engineered tissue products made there fall under 21 CFR Part 1271 as well as the drug and biologics rules where they apply. Section 1271.230 requires a process to be validated and approved where its results cannot be fully verified by later inspection and testing, section 1271.200 requires equipment of appropriate design installed to allow cleaning and maintenance, and section 1271.195 requires control of temperature, humidity, ventilation, air filtration and cleaning where conditions could cause contamination. In converted mill buildings, those requirements meet old structure, so air handling, room pressurization and utility routing have to be proven in rooms that were never designed as cleanrooms. The room side of that work is covered on the cleanrooms in New Hampshire page.
Commercial biologics in West Lebanon and the Upper Valley
Novo Nordisk’s West Lebanon plant, established in 1989 and acquired from Olympus Biotech in 2014, makes hemophilia and growth hormone disorder products by mammalian cell culture in a 215,000 square foot facility. A commercial plant of that kind keeps its systems in a qualified state for years: change control on every modification, requalification after major work, periodic review of utilities and equipment, and qualification of replacement equipment that matches the original intent. Among pharmaceutical companies in New Hampshire, it is the clearest case of qualification as a continuing program rather than a one-time event.
Device plants and the February 2026 QMSR
Medical device companies in New Hampshire, including instrument, component and electronics makers in Nashua, Salem, Manchester and Keene, came under the Quality Management System Regulation on February 2, 2026, when FDA’s amended 21 CFR Part 820 took effect and incorporated ISO 13485:2016 by reference. For qualification, the practical effect is that process validation follows clause 7.5.6 of ISO 13485, sterilization and sterile barrier validation follow clause 7.5.7, and the work environment and contamination controls of clause 6.4 have to be shown to work. Medical device manufacturers in New Hampshire that already validated their processes under the old Quality System Regulation now map that evidence to the ISO clause structure the FDA inspects against.
When is commissioning required on a New Hampshire project?
Commissioning on a New Hampshire project is required by the product rules, the owner’s contract and certain funding programs, rather than by the state energy code. When New Hampshire adopted the 2018 International Energy Conservation Code, its Building Code Review Board deleted Section C408, the system commissioning section, by amendment EN-18-04-21, and the 2018 IECC with the Board’s amendments remains the energy code under RSA 155-A. The commercial energy code commissioning requirement that many states enforce at the final mechanical inspection therefore has no counterpart in New Hampshire’s code.
The question of when is commissioning required is answered instead by what the building makes and who pays for it. A drug or biologics plant needs commissioned and qualified equipment under 21 CFR 211.63 and 211.68, a cell or tissue facility under 21 CFR 1271, and a device plant under the QMSR. Owners pursuing green building certification, federal grants or institutional standards write commissioning into their requirements. Boilers, autoclaves, clean steam generators and other pressure vessels above the RSA 157-A:6 exemptions need a valid state inspection certificate before they operate under RSA 157-A:10, so that certificate is a hold point ahead of any operational qualification on steam.
Commissioning vs testing vs validation: three different questions
Commissioning vs testing vs validation is a matter of what each activity proves. Testing answers whether a component or system meets a specific requirement at a moment in time, such as a hydrostatic test, a filter integrity test or a loop check. Commissioning answers whether the whole system was installed as designed and performs as the owner intended, using many tests organized around the owner’s project requirements. Validation answers whether a process, run on qualified systems, consistently delivers product of the required quality, with evidence approved by the quality unit and kept for inspection.
The difference between validation and commissioning matters most in who approves the result and what the record is for. Commissioning results belong to engineering and are used to accept the work; qualification and validation results belong to the quality unit and are used to release product. Under ASTM E2500 and the ISPE commissioning and qualification guide, well-documented commissioning tests on critical aspects are used as qualification evidence when the quality unit approves the plan in advance, which removes repeated testing without weakening the record. Paul Industries writes commissioning and qualification protocols together for that reason, so each test is run once and counted in the right place.
Is commissioning part of construction?
Commissioning is part of construction in practice, but it starts before construction and ends after it. ASHRAE Guideline 0 describes a process that begins in predesign with the owner’s project requirements, continues through design review, carries through construction with installation checks and functional tests, and extends into occupancy with seasonal testing and a final report. On a GMP project, the qualification phases sit on top of that: design qualification during design, installation qualification as systems are completed, operational qualification once they run, and performance qualification under real or simulated production.
| Stage | What happens | Key documents | Typical hold point |
|---|---|---|---|
| Planning | User requirements, system impact and risk assessment, validation master plan | URS, risk assessment, VMP, commissioning plan | Quality unit approval of the plan |
| Design review and qualification | Design checked against requirements and critical aspects | Design review records, traceability matrix | Approved design before fabrication |
| Factory acceptance test | Skid or equipment tested at the builder before shipment | FAT protocol and report, punch list | Release to ship |
| Site acceptance and installation checks | Installation verified against drawings, materials and welds | SAT, IQ protocol, weld and material records | State certificate for steam vessels before operation |
| Operational qualification | Functions, alarms, interlocks and ranges tested | OQ protocol and report, deviations | Quality approval of IQ before OQ starts |
| Performance qualification | System proven under real or simulated load over time | PQ protocol and report, sampling data | Phased water sampling, mapping, media fills where required |
| Release and ongoing control | System released; change control and periodic review begin | Summary report, periodic review schedule | Quality unit release to production |
Qualifying water, clean steam and gases at a New Hampshire plant
Qualifying water, clean steam and process gases at a New Hampshire plant follows the United States Pharmacopeia and the plant’s own specifications. Purified water and water for injection are qualified in phases, with intensive sampling at every point of use over several weeks, then a longer period confirming stability through seasonal changes in feed water, measured for conductivity under USP 645, total organic carbon under USP 643, microbial counts and, for water for injection, endotoxin under USP 85. Clean steam is tested at the point of use for non-condensable gases, superheat and dryness, the tests set out in EN 285, and its condensate is tested against water for injection limits.
Compressed air, nitrogen and carbon dioxide used in direct contact with product or in cell culture are tested for particles, moisture, oil and microbial content against the plant’s acceptance criteria. Paul Industries ties every sampling point to the as-built drawings, so the qualification report and the installed system describe the same pipe. Systems built for that work are described on the ultrapure water systems in New Hampshire, high-purity water systems in New Hampshire and CIP and SIP systems in New Hampshire pages, and the welded piping and its records on the process piping in New Hampshire page.
Computerized systems and data integrity
Computerized systems at a New Hampshire plant, from a skid’s controller to the building management system, environmental monitoring and the historian, are validated so their records meet 21 CFR Part 11 and the data integrity expectations FDA applies under the predicate rules. Paul Industries scales the effort to risk following GAMP 5: configured standard products are verified against requirements and supplier documentation, while custom code is tested in depth. Every validated system is checked for unique user accounts, role-based access, audit trails that capture who changed what and when, electronic signatures where records are signed, time synchronization, and backup and restore, and the results are kept with the system’s qualification file.
From qualified equipment to process performance qualification
Process validation at a New Hampshire drug or biologics plant follows the three stages of FDA’s 2011 guidance: process design, process qualification and continued process verification. Equipment, utility and facility qualification is the first half of stage two; the second half is process performance qualification, in which commercial-scale batches are run under a written protocol to show the process performs as designed. Stage three then tracks process data for the life of the product, with statistical trending that flags drift before it becomes a deviation.
The link between the stages is traceability. A process performance qualification protocol relies on the operating ranges, alarm limits and sampling points proven during operational qualification, so any gap there shows up as a question during the batch run. Paul Industries builds that traceability into the qualification reports, listing the proven ranges for each critical parameter so process development and manufacturing teams set their batch records against tested limits.
Why do we need commissioning on a regulated New Hampshire project?
Commissioning on a regulated New Hampshire project is needed because qualification depends on systems that already work. A purified water loop that has never been balanced, an air handler whose pressure cascade drifts, or a controller with untested alarms produces deviations the moment qualification starts, and each deviation adds investigation, retesting and delay before product release. Commissioning finds and fixes those problems under engineering control, before the quality unit’s clock starts. It also produces the as-built records, test data and operator training the plant relies on for years after turnover.
Cleanroom qualification under ISO 14644
Cleanroom qualification at New Hampshire cell therapy, biologics and device sites follows ISO 14644-1 for classification by airborne particle concentration and ISO 14644-2 for the monitoring plan that proves the room stays in class. The room is tested at rest and, where the product rules call for it, in operation, after the air handling has been commissioned and balanced. Aseptic processing rooms add airflow visualization to show that air moves from clean to less clean areas and sweeps the critical zone, and the environmental monitoring program begins once the room is released.
| Test | Reference | What it shows | When it is repeated |
|---|---|---|---|
| Particle count classification | ISO 14644-1 | The room meets its ISO class at the stated occupancy state | At the interval in the monitoring plan, and after major changes |
| Installed filter leak test | ISO 14644-3 | HEPA filters and their seals have no leaks above the acceptance limit | After filter replacement and at the site’s set interval |
| Airflow volume and velocity | ISO 14644-3 | Air change rate and unidirectional flow velocity meet design | With classification, and after air handling work |
| Room pressure differential | ISO 14644-3; site requirements | Pressure cascade between rooms holds in the right direction | Monitored continuously, verified with requalification |
| Recovery test | ISO 14644-3 | The room returns to its class within the target time after a particle challenge | At initial qualification and after significant changes |
| Airflow visualization | FDA aseptic processing guidance; site requirements | Air sweeps critical zones without turbulence back toward product | At initial qualification and after layout or equipment changes |
Change control and periodic review after release
Change control and periodic review keep a New Hampshire site’s systems qualified after release, and they generate most of the qualification work a mature plant buys. Every modification, from a replaced valve to a software upgrade, is assessed for its effect on the qualified state, and the assessment decides whether the change needs a simple verification, a partial requalification or a full repeat of the protocol. Periodic review, usually yearly for critical utilities and equipment, looks back over deviations, alarms, maintenance, calibration and monitoring trends to confirm the system still performs as qualified.
Paul Industries writes change assessments and requalification protocols to the site’s procedures, executes them during the plant’s work windows and updates drawings, system descriptions and qualification summaries at the same time, so the next inspector finds one consistent record. Typical requalification triggers at New Hampshire sites are suite conversions between products, equipment added between campaigns, controller and historian upgrades, air handler and filter replacement, and repairs to water and steam systems.
What does validation and commissioning in New Hampshire cost?
Validation and commissioning in New Hampshire is priced on the number and complexity of systems, their GMP impact, the depth of testing the risk assessment calls for, the protocol format the quality unit requires, review and approval cycles, and how much of the work happens inside an operating, gowned facility. A direct-impact water for injection system with phased sampling and automated controls takes far more effort than a no-impact utility that needs commissioning alone, and a multi-product suite adds cleaning validation for every changeover.
The surest route to a reliable price is a system list with impact ratings, the user requirements, the site’s validation master plan or protocol templates, and the construction schedule. Paul Industries gives a budget range from comparable programs early, and a firm price once the system list, the deliverables and the approval workflow are agreed.
Who performs validation and commissioning in New Hampshire?
Paul Industries performs validation and commissioning in New Hampshire for biologics, cell therapy, regenerative, device and research facilities, combining commissioning, qualification and computerized system validation under one contract and one schedule. Paul Industries has its headquarters at 256 Shore Drive in Kilmarnock, Virginia, was earlier based in northern New Jersey and then Pennsylvania, and takes qualification programs across New Hampshire, in all 50 states and at regulated plants overseas. Companies with regulated sites in several states see the same approach on the validation and commissioning in Virginia page for the headquarters state, the validation and commissioning in Massachusetts and validation and commissioning in Connecticut pages, and regionally on the New England page. Computer rooms and data halls are covered on the data center commissioning in New Hampshire page.
Commissioning and qualification from Paul Industries for New Hampshire sites
Paul Industries plans, writes, executes and reports commissioning and qualification for New Hampshire biologics plants, cell therapy suites, regenerative manufacturing facilities, device makers and research buildings, from Portsmouth and Dover to Manchester, Nashua, Concord, Keene and Lebanon, on systems it builds and on systems already installed. The New Hampshire page sets out the state’s industries and codes. Send the system list, user requirements and your schedule, call 201-450-8280 or request a quote.
Standards referenced: 21 CFR 210 and 211 (drug cGMP) · 21 CFR 600 to 610 (biologics) · 21 CFR 1271 (HCT/Ps, current good tissue practice) · 21 CFR 820 Quality Management System Regulation (ISO 13485:2016) · 21 CFR Part 11 · FDA Guidance: Process Validation, General Principles and Practices (2011) · ASTM E2500 · ISPE Baseline Guide Volume 5: Commissioning and Qualification · GAMP 5 · USP <1231>, <645>, <643>, <85> · EN 285 · ISO 14644-1 and 14644-2 · ASHRAE Guideline 0 · RSA 155-A and the 2018 IECC as amended in New Hampshire · RSA 157-A (New Hampshire boilers and pressure vessels)
Frequently asked questions
Which qualification work do biotech companies in Portsmouth, NH and at the Pease Tradeport need?
Biologics and cell therapy producers in Portsmouth and at the Pease Tradeport need suite qualification, water for injection and clean steam qualification, cleaning validation between products, cryogenic storage and controlled rate freezer qualification, and requalification after changes. Paul Industries writes and executes those protocols to the site’s templates, so the reports drop straight into the quality unit’s review and approval workflow.
Does Paul Industries qualify cleanrooms and equipment for biotech companies in Manchester, NH?
Yes. Paul Industries commissions and qualifies cleanrooms, air handling, bioreactors, incubators, biosafety cabinets, freezers and process gases for regenerative and biotechnology tenants in Manchester’s Millyard and the surrounding ReGen Valley. Work in converted mill buildings proves room pressurization, airflow and environmental control against 21 CFR 1271 expectations in spaces that started life as manufacturing floors.
Who handles requalification at commercial biologics plants in West Lebanon and the Upper Valley?
Paul Industries handles requalification and change control testing at commercial biologics and research sites in West Lebanon, Lebanon and Hanover. Typical scopes are periodic review of utilities, requalification after equipment replacement or major repair, temperature mapping of cold rooms and freezers, and computerized system revalidation after software upgrades, each documented to the site’s procedures.
Does Paul Industries take device plant validation in Nashua, Salem and Londonderry?
Paul Industries validates processes and qualifies equipment for device and precision plants in Nashua, Salem, Londonderry and Hudson, including cleanrooms, cleaning and passivation lines, molding and assembly equipment, and the utilities that feed them. Protocols follow the plant’s quality system and are mapped to the ISO 13485 clauses the QMSR now applies.
What do biotech companies in New Hampshire need qualified before a first GMP campaign?
Before a first GMP campaign, a New Hampshire biotech company needs its production equipment, critical utilities, cleanrooms, controlled temperature units and data systems qualified, its cleaning procedures validated and its environmental monitoring program running. Paul Industries sequences that work so utilities qualify first, rooms next and equipment last, which keeps the campaign date realistic.
Which rules apply to pharmaceutical companies in New Hampshire when they add a new suite?
A new suite at a drug or biologics plant follows 21 CFR 210 and 211, and 600 to 610 for biologics, with equipment qualified under 211.63 and 211.68 and computerized systems under Part 11. If the suite adds steam-heated or pressure equipment, its New Hampshire inspection certificate under RSA 157-A must be in place before the equipment operates, ahead of operational qualification.
How did the QMSR change validation for medical device companies in New Hampshire?
Since February 2, 2026, FDA inspects device makers against 21 CFR 820 as amended, which incorporates ISO 13485:2016. Process validation now maps to clause 7.5.6, sterilization validation to clause 7.5.7, and work environment controls to clause 6.4. New Hampshire device plants reorganize existing validation evidence to that structure and fill any gaps it reveals.
What is the difference between validation and commissioning when the same test serves both?
When one test serves both, the difference lies in the approval. A commissioning test is accepted by engineering; to count as qualification evidence, the protocol must be approved by the quality unit before execution and the test must cover a critical aspect, as ASTM E2500 describes. Paul Industries writes those tests once with both approvals in place.
Does New Hampshire's energy code require building commissioning?
New Hampshire’s energy code, the 2018 IECC as amended under RSA 155-A, has its Section C408 system commissioning requirement deleted by state amendment. Commissioning on New Hampshire buildings therefore comes from FDA rules for regulated products, owner requirements, green building programs and funding conditions, and Paul Industries scopes it to whichever of those applies.
Does an autoclave in a New Hampshire facility need a state certificate before qualification?
An autoclave whose chamber or jacket is a pressure vessel above the RSA 157-A:6 exemptions must hold a valid New Hampshire inspection certificate before it operates, under RSA 157-A:10. Paul Industries confirms the certificate and the vessel data report during installation qualification and schedules operational qualification and load mapping after the certificate is issued.
How is a cell therapy process validated under 21 CFR 1271?
Under 21 CFR 1271.230, a process whose results cannot be fully verified by later inspection and testing must be validated and approved, with the activities, results, date and approver documented. In practice that means qualified equipment and rooms, aseptic process simulations where the process is open, and validated cryopreservation and storage, with any change revalidated before use.
How are cryogenic freezers and liquid nitrogen storage qualified?
Controlled rate freezers are qualified for profile accuracy and repeatability with load probes, and liquid nitrogen vapor storage is mapped for temperature distribution at each rack level, with alarms, fill controls and oxygen depletion monitoring tested. Paul Industries also qualifies the nitrogen supply piping and records the fill system’s alarm and shutdown functions.
Commissioning vs testing: is a factory acceptance test enough?
A factory acceptance test proves a skid works at the builder’s facility, but commissioning still has to prove it works once installed, connected to site utilities and controls, and operated by the plant. Paul Industries uses well-documented FAT results to reduce site testing where the quality unit agrees, and repeats the tests that installation could affect.
Who performs IQ and OQ on systems already running at a New Hampshire site?
Paul Industries performs installation and operational qualification on systems already installed at New Hampshire sites, including equipment that has run for years without a complete record. The work starts with a walkdown against drawings and documents, recovery of missing records such as material certificates or calibration reports, and a gap assessment, then moves into protocols written to the site’s templates.
How long does a CQV program take for a New Hampshire suite?
Duration depends on the number of systems, their impact and the approval cycle. Phased water qualification alone runs several weeks of intensive sampling before the system is released for use, and cleanroom, equipment and computerized system qualification run alongside it. Paul Industries builds the schedule from the system list and the site’s review times.
Which delivery routes does Paul Industries offer for validation and commissioning?
Paul Industries offers commissioning and qualification as part of a design-build or complete installation project it delivers, as a standalone program for systems already in place, or as protocol writing and execution to the site’s own templates. Many New Hampshire sites combine routes, with the systems Paul Industries builds qualified in the same program as existing equipment.
What should a New Hampshire site send to start a qualification proposal?
Send the system list with impact ratings, user requirements, drawings and supplier documents, the site’s validation master plan or protocol templates, the review and approval workflow, and the construction or campaign schedule. Paul Industries returns a budget range from comparable programs first and a firm price once deliverables are agreed.
Qualifying new systems at a New Hampshire site?
Send the system list, user requirements, protocol templates and your schedule. Call 201-450-8280 or request a quote.
